Stock of the Day

July 10, 2026

Johnson & Johnson (JNJ)

$258.48
-$4.92 (-1.9%)
Market Cap: $634.06B

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson Bull Case

Here are some ways that investors could benefit from investing in Johnson & Johnson:

  • The stock has received multiple "buy" ratings from reputable analysts, indicating strong confidence in its future performance.
  • Recent price targets from analysts suggest a potential upside, with estimates ranging from $263.00 to $275.00, which could lead to significant returns for investors.
  • The current stock price is around $241, which may present a buying opportunity for investors looking for value in a well-established company.
  • Johnson & Johnson has a diverse product portfolio across pharmaceuticals, medical devices, and consumer health, which can help mitigate risks associated with market fluctuations.
  • With a consensus rating of "Moderate Buy," the overall sentiment among analysts is positive, suggesting that the stock is likely to perform well in the near future.

Johnson & Johnson Bear Case

Investors should be bearish about investing in Johnson & Johnson for these reasons:

  • Insider selling activity, such as the recent sale of 10,000 shares by an executive vice president, may raise concerns about the company's future prospects.
  • Despite positive ratings, the stock has seen fluctuations, and the current price may not reflect its long-term growth potential.
  • Corporate insiders own only a small percentage (0.16%) of the company's stock, which could indicate a lack of confidence in the company's future performance.
  • Market conditions can be unpredictable, and external factors such as regulatory changes or economic downturns could negatively impact Johnson & Johnson's performance.
  • While the company has a strong reputation, competition in the healthcare sector is fierce, and new entrants could challenge its market position.
← Previous Stock of the Day

Recent News